Protagonist Therapeutics, Inc Increase (Decrease) in Other Operating Liabilities
Protagonist Therapeutics, Inc (PTGX) reported Increase (Decrease) in Other Operating Liabilities of -$121.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-02-27
- Protagonist Therapeutics, Inc increase (decrease) in other operating liabilities for the quarter ending 2020-12-31 was -$49.00K.
- Protagonist Therapeutics, Inc increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was $78.00K.
- Protagonist Therapeutics, Inc increase (decrease) in other operating liabilities for fiscal 2021 was -$121.00K, a 200.00% decline from fiscal 2020.
- Protagonist Therapeutics, Inc increase (decrease) in other operating liabilities for fiscal 2020 was $121.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$121.00K 10-K · filed 2024-02-27 | |||
| 2020-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $29.00K derived: sum of 2 quarters · filed 2023-03-15 | $121.00K 10-K · filed 2023-03-15 | |
| 2020-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $170.00K 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $92.00K 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |